Suppr超能文献

由IFT140单等位基因致病变异引起的非典型常染色体显性多囊肾病的临床谱与预后

Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140.

作者信息

Zagorec Nikola, Calamel Alizée, Delaporte Margaux, Olinger Eric, Orr Sarah, Sayer John A, Pillay Vignesh-Guru, Denommé-Pichon Anne-Sophie, Tran Mau-Them Frederic, Nambot Sophie, Faivre Laurence, Ars Elisabet, Torra Roser, Ong Albert C M, Devuyst Olivier, Perico Noberto, Després Aurore Michel, Lemoine Hugo, de Fallois Jonathan, Brousse Romain, Hummel Aurélie, Knebelmann Bertrand, Maisonneuve Nathalie, Halbritter Jan, Le Meur Yannick, Audrézet Marie-Pierre, Cornec-Le Gall Emilie

机构信息

Service de Néphrologie, Hémodialyse et Transplantation Rénale, Centre de Référence MARHEA, Brest; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia; Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia.

Service de Néphrologie, Hémodialyse et Transplantation Rénale, Centre de Référence MARHEA, Brest.

出版信息

Am J Kidney Dis. 2025 Apr;85(4):465-476.e1. doi: 10.1053/j.ajkd.2024.10.009. Epub 2024 Dec 26.

Abstract

RATIONALE & OBJECTIVE: Monoallelic predicted loss-of-function (pLoF) variants in IFT140 have recently been associated with an autosomal dominant polycystic kidney disease (ADPKD)-like phenotype. This study enhanced the characterization of this phenotype.

STUDY DESIGN

Case series.

SETTING & PARTICIPANTS: Seventy-five among 2,797 European individuals with ADPKD-like phenotypes who underwent genetic testing that revealed pLoF IFT140-variants.

FINDINGS

The 75 individuals (median age 56 years, 53.3% females) were from 61 families and were found to have 41 different monoallelic pLoF IFT140-variants. The majority of individuals presented with large, exophytic kidney cysts (median total kidney volume, 688mL [IQR, 201-4,139]), and 90.2% were classified using the Mayo Imaging Classification as Mayo Class 2A. Arterial hypertension was present in 50.7% of the individuals (median age at diagnosis, 59 years [IQR, 29-73]). Only 1 patient developed kidney failure (at age 69 years). A significant difference was observed in the age-adjusted estimated glomerular filtration rate (eGFR) between the male and female patients (P<0.001), and 56.3% of the individuals over the age of 60 years had an eGFR of<60mL/min/1.73m. The estimated genetic prevalence of monoallelic pLoF IFT140 variants was 19.76 (95% CI, 18.8-20.7) and 27.89 (95% CI, 23.8-31.9) per 10,000 in the Genome Aggregation Database and the 100,000 Genomes Project (100kG), respectively. Only cystic kidney disease (ICD-10 Q61) was associated with pLoF IFT140 variants (P = 2.9 × 10, odds ratio = 5.6 (95% CI, 3.3-9.2) in 100kG.

STUDY LIMITATIONS

Retrospective study; IFT140-related cystic kidney disease may not be diagnosed in younger patients or patients with milder forms.

CONCLUSIONS

Individuals with monoallelic IFT140 pLoF variants are likely to develop kidney cysts atypical of classic ADPKD and generally have a favorable kidney prognosis.

PLAIN-LANGUAGE SUMMARY: Monoallelic pathogenic variants in IFT140 have been linked to a spectrum of kidney disease clinically similar to autosomal dominant polycystic kidney disease (ADPKD). This article describes a case series of 75 individuals with ADPKD-IFT140. Affected individuals typically presented with an atypical imaging pattern, had fewer but larger kidney cysts compared with classic ADPKD, and rarely developed liver cysts. Although the kidney prognosis appeared better than in classic ADPKD, 56.3% of individuals over 60 years of age had stage 3 or more severe CKD. Individuals with ADPKD-IFT140 variants are likely to develop kidney cyst patterns atypical of ADPKD. Their kidney prognosis appears favorable.

摘要

原理与目的

IFT140基因中的单等位基因预测功能丧失(pLoF)变异最近被发现与常染色体显性多囊肾病(ADPKD)样表型相关。本研究强化了对该表型的特征描述。

研究设计

病例系列研究。

研究地点与参与者

2797名具有ADPKD样表型的欧洲个体中,有75人接受了基因检测,结果显示存在IFT140基因的pLoF变异。

研究结果

这75名个体(中位年龄56岁,女性占53.3%)来自61个家庭,共发现41种不同的单等位基因pLoF IFT140变异。大多数个体表现为巨大的、外生性肾囊肿(中位总肾体积为688mL[四分位间距,201 - 4139]),90.2%的个体根据梅奥影像分类被归为梅奥2A级。50.7%的个体患有动脉高血压(诊断时的中位年龄为59岁[四分位间距,29 - 73])。只有1例患者发展为肾衰竭(69岁时)。在年龄调整后的估计肾小球滤过率(eGFR)方面,男性和女性患者之间存在显著差异(P<0.001),60岁以上个体中有56.3%的eGFR<60mL/min/1.73m²。在基因组聚合数据库和英国十万人基因组计划(100kG)中,单等位基因pLoF IFT140变异的估计基因流行率分别为每10000人中有19.76(95%置信区间,18.8 - 2)和27.89(95%置信区间,23.8 - 31.9)。在100kG中,只有囊性肾病(国际疾病分类第十版Q61)与pLoF IFT140变异相关(P = 2.9×10,优势比 = 5.(95%置信区间,3.3 - 9.2))。

研究局限性

回顾性研究;IFT140相关的囊性肾病在年轻患者或症状较轻的患者中可能未被诊断出来。

结论

携带单等位基因IFT140 pLoF变异的个体可能会发展出与典型ADPKD不同的肾囊肿,且总体肾脏预后良好。

通俗易懂的总结

IFT140基因中的单等位病致病变异与一系列临床上类似于常染色体显性多囊肾病(ADPKD)的肾病有关。本文描述了75例ADPKD - IFT140患者的病例系列。受影响个体通常表现出非典型的影像学特征,与典型ADPKD相比,肾囊肿数量较少但更大,且很少发展为肝囊肿。虽然肾脏预后似乎比典型ADPKD更好,但60岁以上个体中有56.3%患有3期或更严重的慢性肾脏病。携带ADPKD - IFT140变异的个体可能会发展出与ADPKD不同的肾囊肿模式。他们的肾脏预后似乎良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验